The subject of this transformation is a global biotechnology leader at the forefront of biological drug development. Operating on a multinational scale, the organization serves as a critical bridge between cutting-edge laboratory research and patient care. Their mission relies on deep, complex collaborations with Healthcare Organizations (HCOs) and Healthcare Professionals (HCPs) to conduct clinical trials, manage regulatory submissions, and drive commercial pharmaceutical innovation.
Global Biotechnology Leader
Multi-Domain MDM SaaS
HCP, HCO, Product, and Study Data
CRM, Clinical, and Regulatory Systems
As a global leader in biological drug development, the organization managed a vast network of Healthcare Organizations (HCOs) and Healthcare Professionals (HCPs). However, their data infrastructure was fragmented across clinical, regulatory, and commercial platforms.
Inconsistent datasets made it impossible to accurately track and audit interactions with HCPs and HCOs.
A lack of integration between research data and real-world outcomes hindered the ability to draw actionable insights.
Without a single source of truth, the organization struggled with data duplication and conflicting records across global systems.
Inconsistency increased the risk of regulatory non-compliance and slowed the momentum of critical drug development cycles.
We had been trying to implement MDM for over a year, and with the amazing support of the DatAInfa team, we achieved in record time what would have been very difficult otherwise. From product to data management skills, they are always the right team at the right time. Fantastic work—looking forward to many more successful implementations!
Says Key Data Leader of World’s leading multinational retail franchise operator, Kuwait.
The organization moved to a robust, cloud-native Multi-Domain MDM SaaS platform to unify their most critical data entities.
For the first time, HCP, HCO, product, and study data were consolidated into a single, standardized repository.
Established a single source of truth that reconciled conflicting information from disparate clinical and commercial sources.
Achieved seamless data flow between the MDM hub and existing CRM, clinical research, and regulatory management systems.
Leveraged a scalable SaaS model to ensure global accessibility and real-time data updates across all international research hubs.
The implementation of a Multi-Domain MDM strategy transformed the organization’s operational efficiency and research capabilities.
Gained a complete, unified view of HCP/HCO interactions and product study data.
Streamlined data access allowed research teams to link data to outcomes faster, shortening development timelines.
Centralized governance and audit trails ensured all interactions and study data met stringent global healthcare regulations.
Reduced manual intervention through automated ingestion pipelines and standardized data rules.
Provided a high-fidelity data foundation that supports advanced analytics and data-driven drug discovery.
Is fragmented data slowing your clinical or commercial progress? Let’s discuss how we can provide what your organization need
DataINFA is a digital transformation partner that provides services, solutions, and product offerings that are structured to deliver growth and innovation. We provide a wide portfolio of consulting, resource outsourcing, and next-gen IT services that can enable our clients to attain their business goals.
